The efficacy and safety of drug-eluting stents in patients with acute myocardial infarction: Results from Korea Acute Myocardial Infarction (KAMIR)

International Journal of Cardiology

Volumn 163, Issue 1, 2013, Pages 1-4

  Hong, Young Joon ^a   Jeong, Myung Ho ^a   Ahn, Youngkeun ^a   Kang, Jung Chaee ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Acute myocardial infarction; Drug eluting stent

Indexed keywords

PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS;

ACUTE HEART INFARCTION; BARE METAL STENT; CLINICAL EFFECTIVENESS; DIABETES MELLITUS; DISEASE REGISTRY; DRUG ELUTING STENT; HEART DEATH; HEART REINFARCTION; HIGH RISK PATIENT; HUMAN; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; REPEAT PROCEDURE; REVIEW; SOUTH KOREA; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; DEVICE SAFETY; GLOMERULUS FILTRATION; HEART DISEASE; HEART INFARCTION; MEDICAL DEVICE COMPLICATION; PACLITAXEL ELUTING STENT; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SIROLIMUS ELUTING STENT; TARGET LESION REVASCULARIZATION; TARGET VESSEL REVASCULARIZATION; ZOTAROLIMUS ELUTING STENT;

EID: 84873085588     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.02.003     Document Type: Editorial

References (24)

1. M. Joner, A.V. Finn, and A. Farb Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202
2. A.V. Finn, G. Nakazawa, and M. Joner Vascular responses to drug eluting stents: importance of delayed healing Arterioscler Thromb Vasc Biol 27 2007 1500 1510
3. R. Virmani, F.D. Kolodgie, A.P. Burke, A. Farb, and S.M. Schwartz Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions Arterioscler Thromb Vasc Biol 20 2000 1262 1275
4. G. Nakazawa, A.V. Finn, and M. Joner Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study Circulation 118 2008 1138 1145
5. M. Menichelli, A. Parma, and E. Pucci Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI) J Am Coll Cardiol 49 2007 1924 1930
6. C. Spaulding, P. Henry, and E. Teiger Sirolimus-eluting versus uncoated stents in acute myocardial infarction N Engl J Med 355 2006 1093 1104
7. G.J. Laarman, M.J. Suttorp, and M.T. Dirksen Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention N Engl J Med 355 2006 1105 1113
8. D.S. Sim, M.H. Jeong, and J.C. Kang Current management of acute myocardial infarction: experience from the Korea Acute Myocardial Infarction Registry J Cardiol 56 2010 1 7
9. K.Y. Chen, S.W. Rha, and Y.J. Li Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Circulation 119 2009 3207 3214
10. E.M. Ohman, M.T. Roe, and S.C. Smith Jr. Care of non-ST-segment elevation patients: insights from the CRUSADE national quality improvement initiative Am Heart J 148 2004 34 39
11. M. Gulati, S. Patel, A.S. Jaffe, A.J. Joseph, and J.E. Calvin Jr. Impact of contemporary guideline compliance on risk stratification models for acute coronary syndromes in The Registry of Acute Coronary Syndromes Am J Cardiol 94 2004 873 878
12. F.G. Kushner, M. Hand, and S.C. Smith Jr. 2009 focused updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 120 2009 2271 2306
13. V. Pasceri, G. Patti, G. Speciale, C. Pristipino, G. Richichi, and G. Di Sciascio Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction Am Heart J 153 2007 749 754
14. A. Kastrati, A. Dibra, and C. Spaulding Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction Eur Heart J 28 2007 2706 2713
15. G.W. Stone, A.J. Lansky, and S.J. Pocock Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction N Engl J Med 360 2009 1946 1959
16. D.S. Sim, M.H. Jeong, and Y. Ahn Effectiveness of drug-eluting stents versus bare-metal stents in large coronary arteries in patients with acute myocardial infarction J Korean Med Sci 26 2011 521 527
17. E.H. Bae, S.Y. Lim, and Y.H. Choi Drug-eluting vs. bare-metal stents for treatment of acute myocardial infarction with renal insufficiency Circ J 75 2011 2798 2804
18. C.U. Choi, S.W. Rha, and K.Y. Chen Lack of clinical benefit of improved angiographic results with sirolimus-eluting stents compared with paclitaxel and zotarolimus-eluting stents in patients with acute myocardial infarction undergoing percutaneous coronary intervention Circ J 73 2009 2229 2235
19. C.W. Lee, D.W. Park, and S.H. Lee Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction Am J Cardiol 104 2009 1370 1376
20. W.C. Kang, T. Ahn, and K. Lee Comparison of zotarolimus-eluting stents versus sirolimus-eluting stents versus paclitaxel-eluting stents for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: results from the Korean Multicentre Endeavor (KOMER) acute myocardial infarction (AMI) trial EuroIntervention 7 2011 936 943
21. S.R. Lee, M.H. Jeong, and Y.K. Ahn Clinical safety of drug-eluting stents in the Korea acute myocardial infarction registry Circ J 72 2008 392 398
22. Y. Cho, H.M. Yang, and K.W. Park Paclitaxel- versus sirolimus-eluting stents for treatment of ST-segment elevation myocardial infarction: with analyses for diabetic and nondiabetic subpopulation JACC Cardiovasc Interv 3 2010 498 506
23. H.K. Kim, M.H. Jeong, and Y.K. Ahn Comparison of outcomes between zotarolimus- and sirolimus-eluting stents in patients with ST-segment elevation acute myocardial infarction Am J Cardiol 105 2010 813 818
24. M.G. Lee, M.H. Jeong, and Y. Ahn Comparison of paclitaxel-, sirolimus-, and zotarolimus-eluting stents in patients with acute ST-segment elevation myocardial infarction and metabolic syndrome Circ J 75 2011 2120 2127